RxFinder.ai

Nelarabine

Arranon

Nucleoside Metabolic Inhibitor

NADAC/unit N/A
No Shortage 10 Manufacturers 11 ANDAs

Nelarabine interferes with DNA synthesis to slow cancer cell or viral replication.

Market Intelligence

2025-03-12 Class II Recall: Zydus Pharmaceuticals (USA) Inc
2025-03-12 Class II Recall: Zydus Pharmaceuticals (USA) Inc

Generic Manufacturers

ALEMBIC PHARMACEUTICALS LTDAMNEAL EU LTDDR REDDYS LABORATORIES LTDGLAND PHARMA LTDMEITHEAL PHARMACEUTICALS INCMSN LABORATORIES PRIVATE LTDNEXUS PHARMACEUTICALS LLCSANDOZ INCSHORLA PHARMA LTDXGEN PHARMACEUTICALS DJB INCZYDUS PHARMACEUTICALS USA INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Nelarabinedrfinder.aiFind doctors who prescribe Nelarabinerxnews.aiLatest news about Nelarabine

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.